45 related articles for article (PubMed ID: 2963448)
1. Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations.
Demion M; Thireau J; Gueffier M; Finan A; Khoueiry Z; Cassan C; Serafini N; Aimond F; Granier M; Pasquié JL; Launay P; Richard S
PLoS One; 2014; 9(12):e115256. PubMed ID: 25531103
[TBL] [Abstract][Full Text] [Related]
2. Cardiac myocyte cell cycle control in development, disease, and regeneration.
Ahuja P; Sdek P; MacLellan WR
Physiol Rev; 2007 Apr; 87(2):521-44. PubMed ID: 17429040
[TBL] [Abstract][Full Text] [Related]
3. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development.
Li F; Wang X; Capasso JM; Gerdes AM
J Mol Cell Cardiol; 1996 Aug; 28(8):1737-46. PubMed ID: 8877783
[TBL] [Abstract][Full Text] [Related]
4. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy.
Poolman RA; Brooks G
J Mol Cell Cardiol; 1998 Oct; 30(10):2121-35. PubMed ID: 9799664
[TBL] [Abstract][Full Text] [Related]
5. [Hypertrophy or hyperplasia of myocytes in heart hypertrophy?].
Grajek S; Paradowski S; Zajac M; Kaczmarek E
Przegl Lek; 1992; 49(12):395-8. PubMed ID: 1341756
[TBL] [Abstract][Full Text] [Related]
6. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart.
Olivetti G; Cigola E; Maestri R; Corradi D; Lagrasta C; Gambert SR; Anversa P
J Mol Cell Cardiol; 1996 Jul; 28(7):1463-77. PubMed ID: 8841934
[TBL] [Abstract][Full Text] [Related]
7. Specificity of light and electron microscopic features of hypertrophic obstructive and nonobstructive cardiomyopathy. Qualitative, quantitative and etiologic aspects.
Ferrans VJ; Rodríguez ER
Eur Heart J; 1983 Nov; 4 Suppl F():9-22. PubMed ID: 6686548
[TBL] [Abstract][Full Text] [Related]
8. Evidence of myocyte hyperplasia in hypertrophic cardiomyopathy and other disorders with myocardial hypertrophy?
Ferrans VJ; Rodríguez ER
Z Kardiol; 1987; 76 Suppl 3():20-5. PubMed ID: 2963448
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
10. The myocardial cell: normal growth, cardiac hypertrophy and response to injury.
Bishop SP
Toxicol Pathol; 1990; 18(4 Pt 1):438-53. PubMed ID: 2151058
[TBL] [Abstract][Full Text] [Related]
11. Cellular mechanisms of tubule hypertrophy and hyperplasia in renal injury.
Wolf G
Miner Electrolyte Metab; 1995; 21(4-5):303-16. PubMed ID: 7565479
[TBL] [Abstract][Full Text] [Related]
12. Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia.
Anversa P; Kajstura J; Reiss K; Quaini F; Baldini A; Olivetti G; Sonnenblick EH
Ann N Y Acad Sci; 1995 Mar; 752():47-64. PubMed ID: 7755292
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
